DJIA 17,812.28 -2.66 -0.01%
NASDAQ 4,772.60 14.35 0.30%
S&P 500 2,068.77 1.74 0.08%
market minute promo

GlaxoSmithKline (NYSE: GSK)

46.40 0.12 (0.26%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $46.40 0.26%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $46.45
Previous Close $46.28
Daily Range $46.41 - $46.52
52-Week Range $41.91 - $56.73
Market Cap $111.5B
P/E Ratio 15.90
Dividend (Yield) $2.45 (5.7%)
Ex-Dividend Date
Dividend Pay Date
11/05/14
01/08/15
Volume 580,474
Average Daily Volume 4,258,457
Current FY EPS $3.06

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary

3 Value Stocks Near 52-Week Lows Worth Buying

These three value stocks may have taken it on the chin recently, but they could be poised for a quick rebound.

Merck Buys Rights to Ebola Vaccine Candidate from NewLink - Analyst Blog

Rolling With Biotech's Regulatory Punches: Chen Lin

BioMarin Takes Aim at Sarepta

BioMarin's acquisition of Prosensa puts it in direct competition with Sarepta.

Merck obtains right to experimental Ebola vaccine

Stop Worrying About Ebola: This is a Much More Pressing Concern

Ebola may be garnering all of the headlines, but this infectious disease has been a contributing factor to the eighth leading cause of death in the U.S.

Pfizer/Merck KGaA Immune Checkpoint Deal Bodes Extremely Well For Compugen

Sanofi Beats The Drum

Buy-Rated Dividend Stocks: Top 3 Companies: GSK, PBA, ENLK

GlaxoSmithKline vs. Sanofi: Which Is The Better Dividend Stock?

Shares of healthcare giants GlaxoSmithKline and Sanofi have fallen hard this year, resulting in unusually high dividend yields for these two companies. Here is a look at which company offers the better opportunity for income investors moving forward.

See More GSK News...

GSK's Top Competitors

GSK $46.40 (0.26%)
Current stock: GSK
JNJ $106.98 (0.26%)
Current stock: JNJ
NVS $95.38 (0.36%)
Current stock: NVS
RHHBY $37.31 (0.26%)
Current stock: RHHBY